Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas [Phase 2]
A Phase 2 pharmacodynamic study of sitagliptin is planned for patients with progressive grade 4 gliomas, and the trial is currently recruiti…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma [NA]
A clinical trial at Erasmus Medical Center is active but not recruiting, evaluating physiological MRI to guide precision radiotherapy for ID…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
Clinical trial update showing recruitment for a study to evaluate the feasibility of ONCOhabitats to aid surgical and treatment planning in …
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields [Phase 2]
A Phase 2 study is evaluating whether topical clindamycin and triamcinolone can prevent skin-related side effects in patients with glioblast…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery [NA]
A ClinicalTrials.gov listing for a study at Erasmus Medical Center evaluating intraoperative biomarkers to predict prognosis during tumor-re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas [Phase 2]
Phase 2 clinical trial evaluating retifanlimab and epacadostat with radiation and bevacizumab in recurrent gliomas has completed. Results ha…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma [Phase 2]
A Phase 2 clinical trial comparing intraarterial carboplatin plus Caelyx to intraarterial carboplatin plus etoposide phosphate for progressi…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma [Phase 1]
This is a Phase Ib dose-escalation trial evaluating intratumoral administration of IRS-1 HSV C134 in patients with recurrent malignant gliom…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients. [Phase 1]
The Phase 1 feasibility trial (RENEW) evaluating CMV RNA-pulsed dendritic cell vaccines for newly diagnosed glioblastoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases [NA]
This update notes a terminated clinical trial at the University of Southern California evaluating precise dynamic contrast-enhanced MRI (DCE…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma [Phase 2]
A Phase 2 trial evaluating spectroscopic MRI-guided radiation therapy planning for glioblastoma and gliosarcoma has completed with results p…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma [NA]
This University of Miami trial is evaluating spectroscopic MRI, proton therapy, and bevacizumab (Avastin) for recurrent glioblastoma and is …
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
A recruiting study at University Hospital, Bordeaux aims to characterize metabolic, transcriptomic, and proteomic features of relapsed gliob…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
The PEAR-GLIO trial evaluating an AI R&D tool for adult gliomas and other primary brain tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors [NA]
Completed clinical trial evaluating Blood-Brain Barrier Disruption (BBBD) for liquid biopsy in patients with glioblastoma or glioma, sponsor…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma [Phase 2]
This clinical trial update reports a Phase 2 translational study of nivolumab in combination with bevacizumab for recurrent glioblastoma. Th…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy [Phase 1]
This entry reports a Phase 1 clinical trial at the University of Pennsylvania evaluating CART-EGFR-IL13Ra2 CAR-T cells following initial rad…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Implantable Microdevice In Primary Brain Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating an implantable microdevice for primary brain tumors is currently recruiting across multiple gliom…
-
CLINICAL_TRIALS withdrawal · 2025-07-22Clinical Trial Update: A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma [Phase 1]
A Phase 1 clinical trial evaluating bicalutamide with brain re-irradiation for recurrent high-grade glioma/glioblastoma has been withdrawn.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating vaccination with autologous dendritic cells loaded with autologous tumor hom…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases [Phase 2]
Phase 2 trial evaluating crizanlizumab alone or with nivolumab for glioblastoma and melanoma brain metastases is currently recruiting at She…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma [EARLY_Phase 1]
Early-phase clinical trial evaluating the diagnostic PET tracer [68Ga]Ga-XT771 for glioblastoma and clear cell renal cell carcinoma, current…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma [NA]
A clinical trial update describes using molecular profiling to tailor treatments for patients with high-grade glioma, aiming to improve indi…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Fimepinostat in Treating Brain Tumors in Children and Young Adults [EARLY_Phase 1]
This is an early-phase 1 trial update on fimepinostat for pediatric and young adult brain tumors, including DIPG, recurrent anaplastic astro…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
A clinical trial investigating PSMA expression in glioblastoma after VEGF blockade with bevacizumab is currently NOT_YET_RECRUITING. The stu…